Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
Hepatitis C Market Forecast
Market Study
Published: January 2009
Pages: For full details, please email keithw@cmsinfo.com
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 10857.14 Buy Now!
Research from: pharmaceuticalmarketresearch
Sector: Indication Areas
Introduction
The Hepatitis C market was worth $2.3 billion in 2007, declining at a CAGR of -2.8% from 2004-2007. Despite this recent slump, Datamonitor forecasts sales to grow to $4.5 billion by 2017, driven primarily by the launch of the new protease inhibitors. The US and EU will remain the largest markets, generating $1.9 billion and $1.7 billion respectively in 2017.
Reasons to Purchase
*Understand current and future Hepatitis C market dynamics
*Gain insight into the unmet needs of HCV patients and the extent to which pipeline drugs are addressing these issues
*Assess current and future market size and the impact of new drug launches
The Hepatitis C market was worth $2.3 billion in 2007, declining at a CAGR of -2.8% from 2004-2007. Despite this recent slump, Datamonitor forecasts sales to grow to $4.5 billion by 2017, driven primarily by the launch of the new protease inhibitors. The US and EU will remain the largest markets, generating $1.9 billion and $1.7 billion respectively in 2017.
Reasons to Purchase
*Understand current and future Hepatitis C market dynamics
*Gain insight into the unmet needs of HCV patients and the extent to which pipeline drugs are addressing these issues
*Assess current and future market size and the impact of new drug launches